MELLISA POWELL: Open Payments
NPI 1447882121 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 16 payments from 12 companies in 2025. Trend: 2023 $1,666 · 2024 $421 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 2 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| UROGEN PHARMA, INC. | 2 | $49 |
| Telix Pharmaceuticals | 1 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| TOLMAR, INC. | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| DENTSPLY IH AB | 1 | $18 |
| Boston Scientific Corporation | 1 | $15 |
Products named: AVEED, GEMTESA, ILLUCCIX, JOURNAVX, ZUSDURI, ELIGARD, MYRISK, BOTOX.
Industry payments across FL — which companies pay providers there.
